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Abstract. PSEN1 mutations are the most frequent cause of familial Alzheimer’s disease and show nearly full penetrance. Here
we studied alterations in brain function in a cohort of 19 PSEN1 mutation carriers: 8 symptomatic (SMC) and 11 asymptomatic
(AMC). Asymptomatic carriers were, on average, 12 years younger than the predicted age of disease onset. Thirteen healthy
subjects were used as a control group (CTR). Subjects underwent a 10-min resting-state functional magnetic resonance imaging
(fMRI) scan and also performed a visual encoding task. The analysis of resting-state fMRI data revealed alterations in the
default mode network, with increased frontal connectivity and reduced posterior connectivity in AMC and decreased frontal and
increased posterior connectivity in SMC. During task-related fMRI, SMC showed reduced activity in regions of the left occipital
and left prefrontal cortices, while both AMC and SMC showed increased activity in a region within the precuneus/posterior
cingulate, all as compared to CTR. Our findings suggest that fMRI can detect evolving changes in brain mechanisms in PSEN1
mutation carriers and support the use of this technique as a biomarker in Alzheimer’s disease, even before the appearance of
clinical symptoms.
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INTRODUCTION
A minority of Alzheimer’s disease (AD) cases
is inherited with an autosomal dominant pattern of
inheritance [1] and is caused by a genetic mutation.
The mutations identified so far (http://www.molgen.
ua.ac.be) affect the amyloid- protein precursor,
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presenilin-1 (PSEN1), and presenilin-2. These forms,
also called familial AD, show almost 100% penetrance
and have an early age of onset, which is also rela-
tively predictable in a given family [2]. They are a good
model that allows us to look into the early pathogenic
mechanisms of the disease [3].
Altered synaptic function is characteristic of AD
and there is consistent evidence that it is present very
early in the disease process, possibly long before
the development of clinical symptoms or even of
significant neuropathology [4]. Functional magnetic
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resonance imaging (fMRI) is based on the strength
of the blood-oxygen-level-dependent (BOLD) signal
and it is thought to provide an in vivo correlate
of neural activity. Thus, it is particularly useful for
detecting alterations in brain function that may be
present very early in the course of AD [5]. When
examined at rest, fMRI can be used to study pat-
terns of intrinsic brain connectivity or functional
networks [6]. The most widely studied of these pat-
terns is the default mode network (DMN), which
involves the precuneus and posterior cingulate cor-
tex, parietal and temporal cortices bilaterally, and the
medial prefrontal cortex, as well as some regions
within the hippocampal memory system [7, 8]. DMN
regions are typically co-activated during rest and deac-
tivated during the processing of external stimuli, and
they are among the earliest and most consistently
affected regions in AD [9]. DMN functioning and con-
nectivity have been widely assessed along the AD
continuum, with functional connectivity abnormali-
ties being reported in both AD [10–14] and mild
cognitive impairment [15–17]. Furthermore, studies
with cognitively-preserved populations at risk for AD
have shown abnormal connectivity in elderly subjects
with evidence of amyloid deposition [18–21], as well
as in in apolipoprotein (APOE) 4 carriers [22–26].
However, to the best of our knowledge, there are no
published studies assessing the effect of the presence
of a pathogenic PSEN1 mutation on the DMN.
Another fMRI strategy, known as task-related fMRI,
can be used to study brain activity when the sub-
ject is engaged in a given task. By using memory
encoding paradigms, fMRI studies have revealed task-
associated brain activity during encoding in a specific
set of brain regions that include the medial tempo-
ral lobe, prefrontal cortex, and ventral temporal cortex
[5]. During the encoding of new information, patients
with AD have shown decreased fMRI activation in the
hippocampus and related structures within the medial
temporal lobe when compared to their matched control
subjects [27]. However, it has been suggested that there
may be a phase of paradoxically increased activation
earlier in the course of the disease, that is, in prodromal
AD or in individuals at genetic risk for AD [28, 29].
Few encoding-based fMRI studies have been con-
ducted in PSEN1 mutation carriers. Encoding-related
activity was found to be altered in one asymptomatic
mutation carrier (AMC) subject 30 years prior to the
mean familial age of onset [30]. In other studies,
PSEN1 AMC exhibited increased activation in the
right hippocampus and parahippocampus during mem-
ory encoding [31]. Increased fMRI activity was also
reported in the fusiform and middle temporal gyri as
mutation carriers approached the mean familial age of
disease diagnosis [32].
Based on previous work, we hypothesized that
PSEN1 mutation carriers would demonstrate func-
tional connectivity changes in the DMN along disease
progression. We further hypothesized that during
visual memory fMRI, symptomatic mutation carriers
(SMC) would present a pattern of reduced brain activ-
ity similar to what is reported in sporadic AD, and
also that task-related activity within memory networks
would already be altered in AMC compared to nor-
mal controls. In order to test these hypotheses, we
examined brain functioning in a sample of PSEN1
mutation carriers, including both asymptomatic and
symptomatic subjects. Specifically, this was done by
analyzing the DMN during resting fMRI and memory
networks during encoding-based task fMRI.
MATERIALS AND METHODS
Subjects
Nineteen mutation carriers from 8 families with 6
different PSEN1 mutations (M139T, K239N, L235R,
L282R, L286P, I439S) and 13 normal controls, asymp-
tomatic non-carriers, were recruited from the genetic
counseling program for familial dementias (PICO-
GEN) at the Hospital Clinic, Barcelona, Spain [33].
Subjects were made aware of their at-risk status for
genetic AD in a session of genetic counseling and
were given the option of knowing their genetic sta-
tus through the genetic counseling protocol. The study
was approved by the Hospital Clinic ethics committee
and all subjects gave written informed consent.
Genetic analysis
Genomic DNA was extracted from peripheral blood
using the QIAamp DNA Blood Mini Kit (Qiagen).
Mutation screening was performed as previously des-
cribed [34].
Clinical and neuropsychological characterization
Subjects underwent clinical and cognitive assess-
ments, and a comprehensive neuropsychological
battery was also administered, as described previously
[35]. Subjects were classified clinically as asymp-
tomatic (AMC) if they had no memory complaints,
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a normal cognitive assessment, and a score of 0 on
the Clinical Dementia Rating (CDR) scale. They were
classified as symptomatic (SMC) if their cognitive per-
formance was more than 1.5 SD below the mean with
respect to their age and educational level on any cog-
nitive test and/or if their CDR score was >0.
The current sample included 8 families with 6 differ-
ent mutations and different median ages of onset (range
40–54 years). In order to compare subjects from dif-
ferent families, we therefore defined and calculated for
each mutation carrier the adjusted age as the subject’s
age relative to the median familial age of onset.
MRI scanning
All subjects were scanned in a 3T machine (Siemens
Trio Tim, Siemens, Germany) during both a 10-
min resting fMRI protocol and while performing a
visual encoding task. During scanning, a set of T2*-
weighted volumes were acquired (voxel size = 1.7 ×
1.7 × 3.0 mm, TR = 2000 ms, TE = 29 ms, 36 slices
per volume, slice thickness = 3 mm, distance factor
= 25%, FOV = 240 mm, matrix size = 128 × 128).
A high-resolution 3D structural dataset (T1-weighted
MP-RAGE, voxel size = 1.0 × 1.0 × 1.0 mm, TR =
2300 ms, TE = 2.98 ms, 240 slices, FOV = 256 mm,
matrix size = 256 × 256, slice thickness = 1 mm) was
acquired in the same session.
During resting-state, subjects were asked to lie down
in the machine, to not think of anything in particu-
lar, and to avoid falling asleep. For encoding-fMRI,
we employed a visual encoding task used previously
by our group [36]. Briefly, this consisted of a 15-
block design paradigm with alternating “fixation”,
“repeated”, and “encoding” conditions. During “fixa-
tion”, a white cross on a black screen was presented to
the subject; during the “repeated” condition, a sample
image was presented repeatedly to the subject; while
during “encoding”, a set of new colored images was
shown to the subject for each block. The whole ses-
sion lasted 7 minutes and 30 seconds and subjects were
tested for their memory performance outside the scan-
ner in a two-alternative forced-choice task (maximum
score of 50).
Preprocessing and analysis of resting-state fMRI
data
Resting-fMRI data were preprocessed using tools
implemented in both FSL (http://www.fmrib.ox.
ac.uk/fsl/) and AFNI (http://afni.nimh.nih.gov/afni)
softwares. The procedures for data preprocessing
included: removing the first 5 scans, motion correc-
tion [37], skull stripping/removal of non-brain voxels
[38], spatial smoothing (using a Gaussian kernel of
FWHM = 6.0 mm), grand mean scaling of the whole
4D series, temporal filtering (with a bandpass filter,
0.01–0.1 Hz), and removal of linear and quadratic
trends. Nuisance variables were regressed out from
preprocessed resting-fMRI data. These included the 6
motion parameters, global whole-brain BOLD signal,
and white matter and cerebrospinal fluid oscillations.
In order to perform group analyses, we registered each
individual functional acquisition to Montreal Neu-
rological Institute (MNI) standard space by using a
two-step registration with FMRIB’s Linear Image Reg-
istration Tool (FLIRT; [39]), involving the registration
of each individual fMRI set to its anatomical high-
resolution scan and the registration from anatomical
space to the standard MNI template.
Resting-fMRI data were further analyzed using
seed-based connectivity. A region of interest (ROI)
placed in the precuneus/posterior cingulate (spherical
ROI of 6 mm radius centered at MNI coordinates x = 2,
y = −54, z = 24; [40]) was used to assess whole-brain
resting-state functional connectivity. The procedure
for seed-based connectivity was performed on prepro-
cessed resting data as follows: 1) average time-series
were extracted for each subject within the ROI; 2)
these time-series were then used to calculate the tem-
poral correlation against all the voxels in the brain;
and 3) individual correlation maps were transformed
into Z-scores using Fisher’s r to Z transformation, and
then moved to MNI standard space. All Z maps were
concatenated and introduced into a voxel-wise group
statistical analysis using General Linear Modeling.
Group analysis included average connectivity maps for
each group (one-sample t-test) and group differences
(two-sample t-test). Results were corrected for mul-
tiple comparisons using a permutation-based method
with 5000 iterations [41].
Preprocessing and analysis of encoding-fMRI data
Task-fMRI data were analyzed using a model-
driven approach, as implemented in the FMRI Analysis
Tool (FEAT) from FSL. Data preprocessing included
motion correction [37], non-brain removal [38], spa-
tial smoothing with a Gaussian kernel of FWHM
6 mm, grand-mean intensity normalization, and high-
pass temporal filtering (sigma = 50.0 s). Time-series
statistical analysis was carried out for each piece of
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individual functional data using FMRIB’s Improved
Linear Model (FILM) with local autocorrelation cor-
rection [42]. Three regressors were used to model the
different task blocks (encoding, repeated, and fixa-
tion), and three additional regressors, modeling their
first derivatives, were introduced as nuisance variables.
Individual activation maps were computed from the
preprocessed functional data using the “encoding” >
“repeated” images contrast.
In order to assess group-activation maps and group
differences, we performed higher-level analyses using
the General Linear Model and FLAME (FMRIB’s
Local Analysis of Mixed Effects) stage 1 and stage
2 [43–45]. This included averaged maps for the three
groups (CTR, AMC, and SMC) and group comparisons
(CTR versus AMC and CTR versus SMC). Perfor-
mance scores, measured as the number of correctly
recognized images, were introduced as covariates for
the group comparisons.
Two additional correlation analyses were performed
using encoding-fMRI data. First, and in order to assess
brain activity associated with correct coding of new
images, we created a General Linear Model design
in which whole-brain activity maps were regressed
against individual performance scores for the three
groups separately. Then, and based on the results
reported by Braskie et al. [32], who found increased
functional activity as their subjects approached the
age of onset, we evaluated the relationship between
brain activation maps and adjusted age in the AMC
subgroup.
Statistical analysis
Group analyses were conducted using PASW
(Predictive Analytics SoftWare, IBM Corp.) v.18.
Comparisons between groups were performed using
the two-tailed Student’s t test or ANOVA for contin-
uous variables, and a chi square test for categorical
variables.
RESULTS
Demographics, cognitive testing and genetic status
Demographic and clinical data of the participants
are summarized in Table 1. Eight mutation carriers
were SMC, with a mean age of 48.91 years (SD = 7.53).
The remaining 11 mutation carriers were AMC, with
a mean age of 39.09 years (SD = 10.74) and a mean
adjusted age of −11.92 years (SD = 8.96). There were
13 controls (36.27 years ± 7.45). Age and Mini-Mental
State Examination (MMSE) scores did not differ
between controls and AMC (Table 1). As expected,
SMC were older than both controls and AMC, and
they presented significantly different MMSE scores.
Resting-state connectivity
Average default mode network maps
The seed-based connectivity analysis of resting-
state fMRI data from the precuneus/posterior cingulate
ROI (ROI placement is shown in Fig. 1A) identified a
pattern of connectivity that corresponded to the DMN
in each group separately (Fig. 1B–D). The DMN maps
included areas in bilateral parietal regions and both
angular gyri (for the three groups), as well as areas in
the medial prefrontal cortex (only in the control and
AMC groups).
Group differences
Figures 1E–H show the results of voxel-wise group
comparisons of the precuneus/posterior cingulate con-
nectivity maps. When compared to the control group,
AMC showed reduced resting-state connectivity in
areas of the hippocampus, parahippocampal, lingual
and fusiform gyri, the middle temporal cortex and parts
of the precuneus/posterior cingulate, and the lateral
occipital cortex. Conversely, AMC presented increased
connectivity in the paracingulate and anterior cingu-
late, parts of the superior, middle and inferior frontal
cortices, and in the frontal pole.
Table 1
Demographic and clinical data in the different groups.*p < 0.05 compared to controls
Healthy controls (non-carriers) Asymptomatic mutation carriers Symptomatic mutation carriers
(n = 13) (n = 11) (n = 8)
Age (years) 36.27 (7.45) 39.09 (10.74) 48.91 (7.53)*
Relative age (years) NA −11.92 (8.96) 3.35 (2.94)
Education (years) 14 (3.91) 12.45 (2.54) 10.88 (3.09)
Gender (%Female) 53.84 % 63.63 % 62.50%
MMSE 29.54 (0.50) 29.09 (1.04) 19.63 (6.21)*
CDR-total 0 0 1.25 (0.65)*
MMSE, Mini-Mental State Examination; CDR, Clinical Dementia Rating.
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Fig. 1. Seed-based connectivity analysis of resting-state fMRI data. A) Location of the posterior cingulate cortex (PCC) seed in MNI standard
space (spherical ROI of 6 mm radius; MNI coordinates x = 2, y = −54, z = 24). B) Average connectivity maps for healthy controls (CTR). C)
Average connectivity map for asymptomatic mutation carriers (AMC). D) Average connectivity map for symptomatic mutation carriers (SMC).
E-H) Group difference maps corrected for multiple comparisons. All difference maps are thresholded at a corrected family-wise p < 0.05 level.
Maps (G) and (H) include age as a covariate.
The SMC group showed reduced connectivity with
respect to controls in the anterior cingulate and paracin-
gulate, the frontal pole, the medial frontal cortex,
and the superior frontal gyrus. However, SMC had
increased connectivity in supramarginal areas, the
angular gyrus, parietal cortex, precuneus cortex, supra-
calcarine cortex, and lingual/fusiform areas. These
results remain significant when age was included as
covariate.
Encoding-fMRI activity
fMRI data during encoding were available for a sub-
sample of 23 subjects (12 controls, 6 AMC, and 5
SMC subjects). This sample size difference was due
to timing limitations during the scanning session, to
excessive movement and MRI-related artifacts, and to
extremely poor task performance.
Task performance outside the scanner
Memory performance outside the scanner did not
differ significantly between AMC and control sub-
jects. However, there was a trend for AMC subjects to
perform worse than controls [mean (SD) values were
47.54 (2.21) for controls versus 40.84 (7.94) for AMC;
t = 2.14, p = 0.08]. SMC had a poorer performance
outside the scanner (mean: 23.0, SD: 16.32) than
both controls (t = 3.35, p = 0.028) and AMC (t = 2.4,
p = 0.039).
Average maps
All group-average maps revealed the main pattern
of brain regions involved in encoding for novel images
(“encoding” > “repeated” condition). For the control
and AMC groups (Fig. 2A and B, respectively), activ-
ity patterns included the lateral occipital cortex (left
and right), the temporal occipital fusiform cortex, the
middle and inferior temporal gyrus, the lingual gyrus,
and the parahippocampal gyrus. Moreover, in the con-
trol group we also observed activity in the middle and
inferior frontal gyrus bilaterally (although more pro-
nounced in the left hemisphere), as well as in the frontal
medial cortex and paracingulate gyrus (Fig. 2A). The
group-average maps for the SMC group revealed areas
of activity in the lateral occipital cortex, middle tem-
poral gyrus, lingual gyrus, angular gyrus, and fusiform
(Fig. 2C), although to a lesser extent than in controls
and AMC. There was no activity in frontal areas in
SMC.
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Fig. 2. Results of the analysis of task-related fMRI activity in the “encoding > repeated” images condition. A) Average map for the healthy
control (CTR) group. B) Average map for the asymptomatic mutation carrier (AMC) group. C) Average map for the symptomatic mutation
carrier (SMC) group. D) Areas where AMC had greater task-associated BOLD response than did CTR. E) Areas where SMC showed less
task-associated BOLD response than did CTR. F) Areas where SMC had greater task-associated BOLD response with respect to CTR. Maps
(E) and (F) include age as a covariate.
Table 2
Group differences in brain activity during memory encoding. Summary of significant clusters in the “encoding >
repeated” images contrast
Cluster Size (mm2) Cluster p Z max Peak coordinates (MNI)
x y z
Asymptomatic Mutation Carriers > Controls
1 1952 0.000253 4.96 2 −68 24
Symptomatic Mutation Carriers > Controls
1 1276 0.0171 4.05 0 −84 28
Controls > Symptomatic Mutation Carriers
1 1160 0.015 4.33 −38 16 12
2 1220 0.0109 4.89 −54 −74 8
Group comparisons
In the “encoding > repeated” images contrast, AMC
showed increased BOLD activity in comparison with
the control group in regions of the precuneus/posterior
cingulate cortex (Fig. 2D). There were no regions of
increased BOLD activity in the control group with
respect to AMC. SMC showed decreased BOLD activ-
ity with respect to controls in a region within the left
middle and inferior frontal gyri and left frontal oper-
culum, as well as in the left lateral occipital cortex
(Fig. 2E). Conversely, SMC showed areas of increased
BOLD activity in comparison with controls in the pre-
cuneus cortex, the intracalcarine cortex, and in part
of the lingual gyrus (Fig. 2F). The results of all these
comparisons are also summarized in Table 2.
Correlations with task performance
Brain activity was positively correlated with per-
formance outside the scanner in the AMC group.
This positive association involved areas of the right
parahippocampal gyrus, right hippocampus, and right
temporal fusiform and lingual gyrus (Fig. 3A). We
extracted average signal change between repeated and
encoding conditions for each individual within these
regions (Fig. 3A, right panel). Task performance corre-
lated with activity scores in AMC (r = 0.98, p < 0.001)
but not in the control group (r = 0.27, p = 0.42).
Correlations with adjusted age
In AMC, BOLD activity during encoding was pos-
itively correlated with the adjusted age of subjects in
regions within the angular gyrus (r = 0.94, p = 0.005;
Fig. 3B). In other words, subjects who were closer to
their familial age of onset showed greater activation in
these areas.
DISCUSSION
We performed an fMRI study to assess resting-state
and encoding-task activity in a cohort of symptomatic
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Fig. 3. Correlations found with encoding-related brain activity in the asymptomatic mutation carrier (AMC) group. A) Correlations with task
performance. Spatial map of brain regions with significant correlation (left panel) and scatter plot of performance scores and mean BOLD
signal change within significant areas in AMC subjects and healthy controls (CTR) (right panel). B) Correlations with adjusted age within AMC
subjects. Spatial map of brain regions showing significant correlation (left panel) and scatter plot of adjusted age and mean BOLD signal change
in these regions (right panel). All maps are thresholded at a corrected level of p < 0.05.
and asymptomatic PSEN1 mutation carriers and a
group of matched healthy controls. To the best of
our knowledge, this is the first study to examine
intrinsic functional connectivity by means of resting-
state fMRI in PSEN1 subjects. The asymptomatic and
symptomatic subjects showed divergent changes in
connectivity between the anterior and posterior compo-
nents of the DMN, with connectivity being increased in
AMC and reduced in SMC. Conversely, short distance
connections in posterior regions of the DMN were
increased in SMC and decreased in AMC. The anal-
ysis of task fMRI revealed common encoding-related
BOLD activity in areas within the memory network.
Compared to controls, SMC showed reduced activity
in left prefrontal and left occipital cortices. However,
both SMC and AMC presented increased activity dur-
ing encoding compared to controls in areas of the
precuneus/posterior cingulate.
The reduced connectivity from the precuneus/
posterior cingulate to frontal areas in SMC is consis-
tent with previous studies that have assessed the DMN
in sporadic AD and mild cognitive impairment [10,
12, 15]. Moreover, the increased within-lobe functional
connectivity in the same subjects is also in line with
previously published research on sporadic AD [11, 46]
and mild cognitive impairment [15]. However, other
studies on AD have also showed opposite changes
with decreases in functional connectivity of posterior
regions and increases in frontal regions (reviewed in
[47]). These discrepancies may rely on differences in
the methodology used to isolate the DMN together with
differences in subjects’ atrophy between studies.
More interesting, we also found altered connec-
tivity in mutation carriers prior to the appearance
of clinical symptoms. Specifically, AMC subjects
showed reduced resting-state connectivity from the
precuneus/posterior cingulate to other posterior brain
regions, including part of the hippocampus, the
fusiform and parahippocampal gyri, and the lingual
gyrus. These regions are known to be structurally
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affected very early in AD and this reduction in con-
nectivity is in accordance with seed-based studies
that have demonstrated decreased connectivity in AD
between the hippocampus and DMN regions [48]. We
also found an increase in precuneus/posterior cingu-
late functional connectivity within frontal regions. We
suggest two explanations for the increased connectiv-
ity between the posterior and anterior core components
of the DMN in AMC. First, the increased functional
connectivity in the frontal cortex might reflect reor-
ganization mechanisms within the network that serve
to maintain function despite the reduced connectiv-
ity with medial temporal and hippocampal regions of
the DMN found in AMC. These increases in frontal
areas agree with studies identifying the frontal lobe as
a key region for functional compensation mechanisms
in AD [49]. On the other hand, the increased functional
connectivity might also reflect aberrant excitatory
responses to early amyloid-deposition that could trig-
ger a variety of inhibitory compensatory responses in
memory circuits and would, thus, explain the divergent
network connectivity changes in the medial temporal
lobe and prefrontal regions [4, 29, 50]. Our results are
congruent with the findings in APOE 4 carriers [51,
52] with increased connectivity in frontal regions of
the DMN.
During visual encoding, SMC showed reduced
activity in encoding-associated areas such as the left
occipital and left prefrontal cortex. The results in
SMC confirm the decreased brain activity engaged
by the visual memory task that has been widely
reported in the literature on sporadic AD [27]. AMC
showed increased encoding-related BOLD activity in
precuneus/posterior cingulate with respect to controls.
These results are in agreement with studies of preclin-
ical AD by our group [36] and others [19, 29] and
have been interpreted as a compensatory mechanism,
as the precuneus/posterior cingulate plays an important
role in memory functions. In healthy young con-
trols, precuneus/posterior cingulate deactivates during
encoding and is activated in retrieval, a phenomenon
known as the encoding/retrieval flip. Impaired ability
to modulate activity in the precuneus/posterior cingu-
late has been associated with increasing age, greater
amyloid burden, and worse memory performance [53]
and has also been described in healthy APOE 4 carri-
ers [54–57], and in a previous study in another sample
of PSEN1 asymptomatic carriers [58]. The hyperactiv-
ity (or lack of deactivation) in the precuneus/posterior
cingulate could be a consequence of amyloid depo-
sition, that would produce a decrease in synaptic
inhibition and modify the functional properties of the
neurons themselves, rendering them hyperactive [59]
or a compensatory mechanism, in the sense that addi-
tional cognitive resources are required to achieve and
maintain a performance level similar to that of non-
carriers. In the same sense, a previous study of PSEN1
mutation carriers showed that fMRI activity in the
fusiform and middle temporal gyri increased as sub-
jects approached the age of symptom onset, suggesting
that during novelty encoding, increased fMRI activity
may relate to incipient AD processes [32, 60].
Of note, we also found a significant correlation both
between brain activity and performance outside the
scanner and between brain activity and adjusted age in
the AMC group. First, activity in areas in the right mid-
dle temporal and right hippocampus correlated with
task performance, indicating that the system might be
already compromised prior to the appearance of symp-
toms. In the same sense, positive correlations between
hippocampus activity and encoding performance have
previously been reported in PSEN1 mutation carriers
[30, 31]. The positive correlation between adjusted age
and brain activity in a region within the left angular
gyrus is in agreement with the study published by the
group of Braskie et al. also based on a visual encoding
task [61]. These results, together with the previously
discussed hyperactivity in the precuneus/posterior cin-
gulate, suggest that the activity of other regions such as
the hippocampus or the angular gyrus would compen-
sate in PSEN1 mutation carriers a precocious alteration
in the encoding/retrieval flip.
Thus, taken together, our results would support the
possibility of a phase of paradoxically increased acti-
vation early in the course of the disease that evolves
over the course of the AD disease process [5, 28].
The present study therefore provides evidence to sup-
port that fMRI may be a suitable biomarker in familial
AD to track longitudinally disease progression. In con-
trast, the distinct and evolving changes in the DMN in
PSEN1, with increases followed by decreases in func-
tional connectivity in some areas, might complicate the
interpretation of cross-sectional results.
The main limitation of our study is the relatively
small sample size. However, previous investigations
in familial AD neuroimaging all have similar sample
sizes and the main results survived a correction for
multiple comparisons.
In summary, PSEN1 mutation carriers present dis-
ruption of normal connections in large-scale networks
over a decade before symptoms onset. However, the
trajectory of changes during the AD disease process
may be complex, with increases and decreases in func-
tional connectivity in different areas of the memory
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systems and the DMN. These changes might reflect
aberrant excitatory responses to amyloid- and sub-
sequent inhibitory responses or functional network
reorganization mechanisms that evolve with disease
progression.
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